🇮🇳IN
Sign In
JA

JAGSNPHARM

NSE

Jagsonpal Pharmaceuticals Ltd

₹211.76

+0.90(+0.43%)

Ownership Score

Index Membership

and the weight we carry

Mutual Fund Ownership

% of each scheme's portfolio

Insider & Deals

who traded, and how close they are to the company

Ownership & Influence

who holds it, and what else they hold

Shared directors

companies with a board member in common

JAGSNPHARM shareholding summary

As of Jun 2026, promoters held 69.06% of Jagsonpal Pharmaceuticals Ltd (up 1.17 points from Mar 2026). Institutions together held 2.92%, of which foreign institutional investors held 2.30% (down 0.14 points from Mar 2026) and domestic institutions held 0.62% (up 0.40 points from Mar 2026). The public held the remaining 28.04% (down 1.40 points from Mar 2026). The company had 24,181 shareholders.

Promoters69.06%
FII2.30%
DII0.62%
Public28.04%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer